NO951498L - Farmasöytisk preparat for behandling av osteoporose - Google Patents

Farmasöytisk preparat for behandling av osteoporose

Info

Publication number
NO951498L
NO951498L NO951498A NO951498A NO951498L NO 951498 L NO951498 L NO 951498L NO 951498 A NO951498 A NO 951498A NO 951498 A NO951498 A NO 951498A NO 951498 L NO951498 L NO 951498L
Authority
NO
Norway
Prior art keywords
osteoporosis
treatment
pharmaceutical preparation
xantohumol
therapeutic agent
Prior art date
Application number
NO951498A
Other languages
English (en)
Norwegian (no)
Other versions
NO951498D0 (no
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Osamu Komiyama
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO951498D0 publication Critical patent/NO951498D0/no
Publication of NO951498L publication Critical patent/NO951498L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO951498A 1994-04-21 1995-04-20 Farmasöytisk preparat for behandling av osteoporose NO951498L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6082852A JPH07285856A (ja) 1994-04-21 1994-04-21 骨粗鬆症治療剤

Publications (2)

Publication Number Publication Date
NO951498D0 NO951498D0 (no) 1995-04-20
NO951498L true NO951498L (no) 1995-10-23

Family

ID=13785904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951498A NO951498L (no) 1994-04-21 1995-04-20 Farmasöytisk preparat for behandling av osteoporose

Country Status (14)

Country Link
US (1) US5679716A (de)
EP (1) EP0679393B1 (de)
JP (1) JPH07285856A (de)
KR (1) KR100350564B1 (de)
AT (1) ATE162073T1 (de)
AU (1) AU695696B2 (de)
CA (1) CA2147419A1 (de)
DE (1) DE69501419T2 (de)
DK (1) DK0679393T3 (de)
ES (1) ES2116642T3 (de)
FI (1) FI951856A7 (de)
HU (1) HUT71603A (de)
NO (1) NO951498L (de)
TW (1) TW284687B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung
KR20060095786A (ko) * 2000-01-27 2006-09-01 다카라 바이오 가부시키가이샤 치료제
EP1277473A4 (de) * 2000-04-10 2005-12-28 Takara Bio Inc Hilfsmittel
US6352726B1 (en) * 2001-01-09 2002-03-05 S. S. Steiner, Inc. Method of killing protozoa
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
US20060233902A1 (en) * 2002-02-14 2006-10-19 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism
AU2002257721A1 (en) * 2002-04-24 2003-11-10 Unilever Plc Use of hop components in foods
DE10240065B4 (de) * 2002-08-30 2004-10-28 Hallertauer Hopfenveredlungsgesellschaft M.B.H. Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt
DE50302729D1 (de) * 2002-12-18 2006-05-11 Doehler Gmbh Xanthohumol-haltiges Getränk
DE602004016486D1 (de) * 2003-04-08 2008-10-23 Kirin Brewery Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
EP1909584A4 (de) * 2005-07-29 2010-07-07 Bioactives Inc Prenylflavonoid-formulierungen
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
EP2392325A1 (de) 2010-06-04 2011-12-07 Universitätsklinikum Münster Neue Verbindungen zur Prävention und/oder Behandlung von Osteoarthrose
KR101323150B1 (ko) * 2011-04-25 2013-10-30 충남대학교산학협력단 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
BR112015001595A2 (pt) * 2012-07-26 2018-06-19 Ta-Xan Ag composição farmacêutica, uso de um extrato torrado, e, método para intensificar um ou mais efeito (s) terapêutico (s) de xantohumol e para a produção de uma composição farmacêutica
JP6009498B2 (ja) * 2014-06-24 2016-10-19 国立大学法人京都大学 アルツハイマー病予防薬
US20180193287A1 (en) 2015-07-02 2018-07-12 John I. Haas, Inc. Hops-based substance and use of the substance
CN105477686B (zh) * 2015-11-30 2019-02-15 长春工业大学 一种包覆黄腐酚的纳米纤维膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794744A (en) * 1972-05-10 1974-02-26 White Tomkins Ltd Purification of hop extracts
US4065574A (en) * 1975-08-29 1977-12-27 The Upjohn Company New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds

Also Published As

Publication number Publication date
US5679716A (en) 1997-10-21
KR950031060A (ko) 1995-12-18
AU1653595A (en) 1995-10-19
EP0679393A3 (de) 1995-11-15
ATE162073T1 (de) 1998-01-15
FI951856L (fi) 1995-10-22
JPH07285856A (ja) 1995-10-31
KR100350564B1 (ko) 2002-12-16
DE69501419D1 (de) 1998-02-19
DK0679393T3 (da) 1998-09-14
HU9501121D0 (en) 1995-06-28
HUT71603A (en) 1996-01-29
FI951856A7 (fi) 1995-10-22
FI951856A0 (fi) 1995-04-19
DE69501419T2 (de) 1998-06-25
EP0679393A2 (de) 1995-11-02
TW284687B (de) 1996-09-01
EP0679393B1 (de) 1998-01-14
AU695696B2 (en) 1998-08-20
NO951498D0 (no) 1995-04-20
CA2147419A1 (en) 1995-10-22
ES2116642T3 (es) 1998-07-16

Similar Documents

Publication Publication Date Title
NO951498D0 (no) Farmasöytisk preparat for behandling av osteoporose
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
DE69520768D1 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
HUP0104258A2 (hu) HMG-CoA reduktáz inhibítort tartalmazó stabil gyógyszerkészítmények
PT998287E (pt) Utilizacao de levobupivacaina
MX9200728A (es) Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
EP1062948A4 (de) Arzneimittel für diastolische herzerkrankungen
NO952411L (no) Midler for behandling av metaboliske bensykdommer
WO1998038985A3 (en) Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
WO1998038986A3 (en) Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
AR003117A1 (es) El uso de derivado de aminotetralina para la preparacion de composiciones farmaceuticas para la terapia de enfermedades cardiovasculares y dichascomposiciones farmaceuticas.
WO2001095916A3 (de) Anticholestatisches arzneimittel
NO890742D0 (no) Farmasoeytisk preparat som sikrer den transdermale absorpsjon av aktiv bestanddel, og fremgangsmaate for fremstilling av dette.
HUP0004475A2 (hu) Gyógyszerkészítmény
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application